SARS-CoV-2 seroprevalence and respiratory disease disability claims in Mexico City Metropolitan Area.

IF 2.4 4区医学 Q2 PUBLIC, ENVIRONMENTAL & OCCUPATIONAL HEALTH

Salud Publica De Mexico Pub Date : 2023-07-15 DOI:10.21149/14545

David Barros-Sierra, Rodrigo Zepeda-Tello, Marcela Tamayo-Ortiz, Hector Osiris Gutiérrez-Díaz, Valeria Aurora Pérez-Chávez, José Antonio Rosa-Parra, Luis Enrique Nieto-Barajas, Mauricio Méndez-Aranda, Luis Alonso Herrera-Montalvo, Mauricio Hernández-Ávila

{"title":"SARS-CoV-2 seroprevalence and respiratory disease disability claims in Mexico City Metropolitan Area.","authors":"David Barros-Sierra, Rodrigo Zepeda-Tello, Marcela Tamayo-Ortiz, Hector Osiris Gutiérrez-Díaz, Valeria Aurora Pérez-Chávez, José Antonio Rosa-Parra, Luis Enrique Nieto-Barajas, Mauricio Méndez-Aranda, Luis Alonso Herrera-Montalvo, Mauricio Hernández-Ávila","doi":"10.21149/14545","DOIUrl":null,"url":null,"abstract":"Objective: To characterize the impact of SARS-CoV-2 infection in workers from an essential large-scale company in the Greater Mexico City Metropolitan Area using point prevalence of acute infection, point prevalence of past infection through serum antibodies and respiratory disease short-term disability claims (RD-STDC).Materials and methods: Four randomized surveys, three during 2020 before and one after (December 2021) vaccines' availability.Outcomes: point prevalence of acute infection through saliva PCR (polymerase chain reaction) testing, point prevalence of past infection through serum antibodies against Covid-19, RD-STDC and prevalence of symptoms during the previous six months.Results: Prevalence of SARS-CoV-2 cases was 1.29-4.88%, on average, a quarter of participants pre-vaccination were seropositive; over half of participants with a RD-STDC had antibodies. The odds of having antibodies were 6-7 times more among workers with an RD-STDC.Conclusions: High antibody levels against Covid-19 in this study population reflects that coverage is high among workers in this industry. STDCs are a useful tool to track workplace epidemics.","PeriodicalId":47913,"journal":{"name":"Salud Publica De Mexico","volume":"65 4, jul-ago","pages":"334-343"},"PeriodicalIF":2.4000,"publicationDate":"2023-07-15","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"Salud Publica De Mexico","FirstCategoryId":"3","ListUrlMain":"https://doi.org/10.21149/14545","RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"Q2","JCRName":"PUBLIC, ENVIRONMENTAL & OCCUPATIONAL HEALTH","Score":null,"Total":0}

引用次数: 0

Abstract

Objective: To characterize the impact of SARS-CoV-2 infection in workers from an essential large-scale company in the Greater Mexico City Metropolitan Area using point prevalence of acute infection, point prevalence of past infection through serum antibodies and respiratory disease short-term disability claims (RD-STDC).

Materials and methods: Four randomized surveys, three during 2020 before and one after (December 2021) vaccines' availability.

Outcomes: point prevalence of acute infection through saliva PCR (polymerase chain reaction) testing, point prevalence of past infection through serum antibodies against Covid-19, RD-STDC and prevalence of symptoms during the previous six months.

Results: Prevalence of SARS-CoV-2 cases was 1.29-4.88%, on average, a quarter of participants pre-vaccination were seropositive; over half of participants with a RD-STDC had antibodies. The odds of having antibodies were 6-7 times more among workers with an RD-STDC.

Conclusions: High antibody levels against Covid-19 in this study population reflects that coverage is high among workers in this industry. STDCs are a useful tool to track workplace epidemics.

查看原文本刊更多论文

墨西哥城大都会区的 SARS-CoV-2 血清流行率和呼吸道疾病伤残索赔。

目的利用急性感染点流行率、通过血清抗体检测的既往感染点流行率和呼吸系统疾病短期伤残索赔（RD-STDC），确定大墨西哥城都会区一家重要大型公司的工人感染 SARS-CoV-2 的影响：结果：通过唾液 PCR（聚合酶链式反应）检测获得急性感染点流行率，通过血清 Covid-19 抗体获得既往感染点流行率，RD-STDC 和前六个月的症状流行率：SARS-CoV-2病例的流行率为1.29%-4.88%，平均四分之一接种前的参与者血清呈阳性；超过一半的 RD-STDC 参与者有抗体。接种过 RD-STDC 的工人出现抗体的几率是其他人的 6-7 倍：结论：本研究人群中 Covid-19 抗体水平较高，反映出该行业工人的感染率较高。STDC 是追踪工作场所流行病的有用工具。

本文章由计算机程序翻译，如有差异，请以英文原文为准。

求助全文

约1分钟内获得全文求助全文

来源期刊

Salud Publica De Mexico PUBLIC, ENVIRONMENTAL & OCCUPATIONAL HEALTH-

CiteScore

3.30

自引率

21.70%

发文量

审稿时长

34 weeks

期刊介绍： Salud Pública de México se crea en 1959 y comienza a publicarse bimestralmente a partir de 1961; en 1988 inicia una nueva época en la que se refuerza su carácter de publicación científica con evaluación por pares. Es una revista publicada por el Instituto Nacional de Salud Pública (INSP), organismo descentralizado de la Secretaría de Salud de México, dedicado a la investigación, docencia y difusión del conocimiento en salud pública. El INSP, de acuerdo con la normatividad internacional, otorga a la revista independencia editorial.